You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Express Scripts
Mallinckrodt
Baxter
Dow

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

LEVEMIR PENFILL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: LEVEMIR PENFILL
Patents:23
Applicants:1
BLAs:1
Suppliers: see list2
Recent Clinical Trials: See clinical trials for LEVEMIR PENFILL
Recent Clinical Trials for LEVEMIR PENFILL

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Medical University of GrazPhase 1

See all LEVEMIR PENFILL clinical trials

Company Disclosures: US Patents for LEVEMIR PENFILL

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Novo Nordisk Inc LEVEMIR PENFILL insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 004 2005-06-16   Get Started for $10 D.C.P. AF 1988 A/S (DK) 2008-02-10 DISCN company
Novo Nordisk Inc LEVEMIR PENFILL insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 004 2005-06-16   Get Started for $10 Novo Nordisk A/S (Bagsvaerd, DK) 2014-04-08 DISCN company
Novo Nordisk Inc LEVEMIR PENFILL insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 004 2005-06-16   Get Started for $10 Novo Nordisk A/S (Bagsvaerd, DK) 2015-05-12 DISCN company
Novo Nordisk Inc LEVEMIR PENFILL insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536 004 2005-06-16   Get Started for $10 Novo Nordisk A/S (Bagsvaerd, DK) 2016-06-20 DISCN company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for LEVEMIR PENFILL

These patents were identified by searching patent claims

Supplementary Protection Certificates for LEVEMIR PENFILL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2004C/020 Belgium   Get Started for $10 PRODUCT NAME: INSULIN DETEMIR; AUTHORISATION NUMBER AND DATE: 56370 01 20040601
PA2004005,C0792290 Lithuania   Get Started for $10 PRODUCT NAME: INSULIN DETEMIR; REGISTRATION NO/DATE: EU/1/04/278/001, EU/1/04/278/002, EU/1/04/278/003, EU/1/04/278/004, EU/1/04/278/005, EU/1/04/278/006, EU/1/04/278/007, EU/1/04/278/008, EU/1/04/278/00 20040601
SZ 28/2004 Austria   Get Started for $10 PRODUCT NAME: INSULIN-DETEMIR UND PHARMAZEUTISCH ANNEHMBARE ZN-SALZE DAVON
SPC/GB04/036 United Kingdom   Get Started for $10 PRODUCT NAME: INSULIN DETEMIR, NEB29- TETRADECANOYL- DES(B30) HUMAN INSULIN; NATL REGISTRATION NO/DATE: EU/1/04/278/001-009 20040601; FIRST REGISTRATION: CH 56370, 56311, 56372 20031110
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Dow
Harvard Business School
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.